T2 Biosystems surged over 80% in morning trading and soared 130% in 2 days on Monkeypox Test News.
According to a press release from the in vitro diagnostics company, it’s weighing the viability of developing a rapid molecular diagnostic test for the monkeypox virus. The company intends to determine both the technical and commercial feasibility of creating such a test.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments